Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-003995

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 69,920 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Paolini John F. CHIEF MEDICAL OFFICER 2022-04-07 Grant or award · Share Option +59,930 59,930 D
Paolini John F. CHIEF MEDICAL OFFICER 2022-04-07 Grant or award · Restricted Share Unit +9,990 9,990 D
Loading xslF345X03/form4-04112022_010455.xml…